Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc.
CSE Index:
Currency:
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nirvana Life Sciences Inc. (NIRV)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
CanadaPhone
(604) 401-8100Email
Info@nirvanalifescience.comWebsite
https://nirvanalifescience.comListing date
Thursday, March 17, 2022Transfer Agent
Computershare Investor Services Inc.SEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
CanadaPhone
(604) 401-8100Email
Info@nirvanalifescience.comWebsite
https://nirvanalifescience.comListing date
Thursday, March 17, 2022Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
33020139Reserved for Issuance:
300000News Releases
18/03/2025
News Release- Share Consolidation
10/10/2023
MCTO Update
Bulletins
21/03/2025
2025-0326 - Consolidation - Nirvana Life Sciences Inc. (NIRV)
Le 21 mars/March 2025
Nirvana Life Sciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the number of outstanding shares will be reduced to approximately 4,823,301 common shares.
The name and symbol will not change.
